CytoDyn Inc. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amortization, Percent
CytoDyn Inc. (CYDY) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amortization, Percent of 2.30% for the 12-month period ending 2025-05-31, per its 10-K filed 2026-08-31.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAmortization · last filed 2026-08-31
- CytoDyn Inc. effective income tax rate reconciliation, nondeductible expense, amortization, percent for fiscal 2025 was 2.30%.
- CytoDyn Inc. effective income tax rate reconciliation, nondeductible expense, amortization, percent for fiscal 2023 was -0.60%.
- CytoDyn Inc. effective income tax rate reconciliation, nondeductible expense, amortization, percent for fiscal 2022 was -0.30%.
- CytoDyn Inc. effective income tax rate reconciliation, nondeductible expense, amortization, percent for fiscal 2021 was -0.60%.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amortization, Percent 12 month |
|---|---|
| 2025-05-31 | 2.30% 10-K · filed 2026-08-31 |
| 2024-05-31 | -0.50% S-1 · filed 2026-04-22 |
| 2023-05-31 | -0.60% 10-K · filed 2024-08-15 |
| 2022-05-31 | -0.30% 10-K · filed 2023-09-14 |
| 2021-05-31 | -0.60% 10-K · filed 2022-08-15 |
| 2020-05-31 | -0.30% 10-K · filed 2022-08-15 |
| 2019-05-31 | 0.00% 10-K · filed 2021-07-30 |
| 2018-05-31 | 0.00% 10-K · filed 2020-08-14 |